SweetValueLab
Write for us

Revvity, Inc. — Intrinsic Value & Fair Price

RVTY
NYSEHealthcareMedical - Diagnostics & ResearchCIK 0000031791revvity.comAbout RVTY
Valuation grade ?C
Quant grade ?B
Last close · Oct 30, 2026157.00−8.78 (−5.30%)
Model value · DCF · Perpetuity growth · 5y
69.91
Revvity closed at $157.00 — overvalued by 125% vs model.
55.53the model's range90.79

DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
7.59 – 184.38
Wall St. target
150.00 5% above
Above model, 1y
30 of 30 days

How it is valued

Valued asMature & Stable
Low/slowing growth (~2% recent)Moderate margins (8% net margin)Highly cyclical earnings
What growth the price implies: the reverse DCF

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.